gvtcx

Proprietary Drugs

key details

Statuscomplete
Category (CPV) 33600000
RegionWales
Deadline21 Jan 2022
Procedureopen
OCIDocds-h6vhtk-0301de

Awards (69)

This procurement was awarded to 69 suppliers. Values shown are per-award; the notice total is ·.

SupplierValueDateStatus
AbbVie Limited shared · · active
Accord-UK Ltd shared · · active
Alliance Pharmaceuticals Ltd shared · · active
Amgen Limited shared · · active
Amicus Therapeutics UK Ltd shared · · active
AMO United Kingdom Ltd shared · · active
Aspen Pharmacare UK Limited shared · · active
Aspire Pharma Ltd shared · · active
Astella Pharma Ltd shared · · active
Astra Zeneca UK Ltd shared · · active
Baxter Health Care Limited shared · · active
Bayer PLC shared · · active
Biogen Idec Limited shared · · active
Bristol-Myers Squibb Pharmaceuticals Ltd shared · · active
Camurus AB shared · · active
Celgene Ltd shared · · active
Chiesi Limited shared · · active
Chugai Pharma UK Limited shared · · active
CIPLA EU Ltd shared · · active
Consilient Health Ltd shared · · active
Correvio GmbH shared · · active
CST Pharma shared · · active
Dr Falk Pharma UK Ltd shared · · active
Drugsrus Limited shared · · active
Eisai Limited shared · · active
Eli Lilly & Company Ltd shared · · active
Ferring Pharmaceuticals Ltd shared · · active
Flexipharm Austrading Ltd shared · · active
Flynn Pharma Ltd shared · · active
Galen Limited shared · · active
Gilead Sciences Limited shared · · active
Glaxo Smithkline shared · · active
Glenmark Pharmaceuticals shared · · active
Intrapharm Laboratories Ltd shared · · active
Ipsen Limited shared · · active
Janssen Limited shared · · active
Kent Pharmaceuticals shared · · active
Laboratories Almirall S.A shared · · active
Lupin Healthcare (UK) Limited shared · · active
Martindale shared · · active
Merck Sharp & Dohme (UK) Limited shared · · active
Mercury Pharmaceuticals Ltd shared · · active
Merz Pharma UK Ltd shared · · active
Morningside Pharmaceuticals Limited shared · · active
Napp Pharmaceutical Group Ltd shared · · active
Neon Healthcare Ltd shared · · active
Norgine Pharmaceuticals Limited shared · · active
Novartis Pharmaceuticals UK Limited shared · · active
Novo Nordisk Pharmaceuticals Ltd shared · · active
Orion Pharma shared · · active
Orphalan shared · · active
Pfizer Limited shared · · active
Pharmasure Ltd shared · · active
Qdem Pharmaceuticals shared · · active
Rayner Pharmaceuticals Ltd shared · · active
Reckitt Benckiser Healthcare shared · · active
Ridge Pharma shared · · active
Roche Products Ltd shared · · active
Sandoz Ltd shared · · active
Sanofi shared · · active
Selective Supplies shared · · active
Takeda UK Limited shared · · active
Teva UK Ltd shared · · active
Theramex shared · · active
Thornton & Ross Ltd shared · · active
Typharm Ltd shared · · active
Viatris UK Healthcare Limited shared · · active
Wockhardt UK Limited shared · · active
Zentiva Pharma UK Limited shared · · active

description

Proprietary Drugs

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
15 Dec 2021 Contract notice (F02) Earlier regulations 031335-2021
14 Jul 2022 Contract award notice (F03) Earlier regulations 019289-2022

more from Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.